Back to Search
Start Over
Liver Fibrosis Market Growth to Accelerate in Forecast Period (2024-2034), DelveInsight Analyzes | Pfizer, AstraZeneca, Gilead Sciences, Galmed R&D, Hepion Pharma, Conatus Pharma, HK inno.N Corp
- Source :
- M2 Presswire. October 9, 2024
- Publication Year :
- 2024
-
Abstract
- M2 PRESSWIRE-October 9, 2024-: Liver Fibrosis Market Growth to Accelerate in Forecast Period (2024-2034), DelveInsight Analyzes | Pfizer, AstraZeneca, Gilead Sciences, Galmed R&D, Hepion Pharma, Conatus Pharma, HK inno.N Corp. [...]
- Subjects :
- Gilead Sciences Inc. -- Growth -- Reports
Pfizer Inc. -- Reports -- Growth
Bristol-Myers Squibb Co. -- Reports -- Growth
AstraZeneca PLC -- Reports -- Growth
Biological products industry -- Industry forecasts
Fibrosis -- Reports
Dapagliflozin -- Reports
BCG vaccines -- Growth -- Reports
Patient compliance -- Reports
BCG -- Growth -- Reports
Liver -- Growth
Epidemiology -- Reports
Liver diseases -- Reports
Pharmaceutical industry -- Industry forecasts
Company growth
Business
Business, international
Subjects
Details
- Language :
- English
- Database :
- Gale General OneFile
- Journal :
- M2 Presswire
- Publication Type :
- News
- Accession number :
- edsgcl.811660106